Skip to main content
OpenTrials

Clinical trial condition

Thrombocythemia, Essential

Explore clinical trials studying Thrombocythemia, Essential. Study availability and eligibility vary by location and protocol.

184 public trials 31 recruiting studies
Refine in advanced search Browse all conditions

Thrombocythemia, Essential trial results

Completed

Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis

NCT00586651

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +12 more
Locations
  • Johns Hopkins University Baltimore, Maryland, United States
  • NY Presbyterian-Cornell New York, United States
  • Mount Sinai School of Medicine New York, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

NCT00134004

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Blood Protein Disorders, +63 more
Locations
  • Blood and Marrow Transplant Program at Northside Hospital Atlanta, Georgia, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Hahnemann University Hospital Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Anagrelide Retard in Essential Thrombocythemia

NCT02076815

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • AOP Orphan Investigational Site Austria 2 Linz, Austria
  • AOP Orphan Investigational Site Austria 1 Vienna, Austria
  • AOP Orphan Investigational Site Austria 3 Wels, Austria
  • AOP Orphan Investigational Site Bulgaria 1 Pleven, Bulgaria
View all 19 locations
View Trial Details
Completed

Exploratory Phase II Study of INC424 Patients With Primary Myelofibrosis (PMF) or Post Polycythaemia Myelofibrosis (PPV MF) or Post Essential Thrombocythaemia Myelofibrosis (PET-MF)

NCT01558739

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +11 more
Locations
  • Novartis Investigative Site Cardiff, Wales, United Kingdom
  • Novartis Investigative Site Bournemouth, United Kingdom
  • Novartis Investigative Site East Yorkshire, United Kingdom
  • Novartis Investigative Site Edinburgh, United Kingdom
View Trial Details
Completed

INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease

NCT01164163

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +37 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Children's Hospital Colorado Center for Cancer and Blood Disorders Aurora, Colorado, United States
View all 24 locations
View Trial Details
Completed

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

NCT00890747

Conditions
AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +199 more
Locations
  • Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • Lombardi Comprehensive Cancer Center at Georgetown University Washington D.C., District of Columbia, United States
  • Northwestern University Chicago, Illinois, United States
  • AIDS - Associated Malignancies Clinical Trials Consortium Rockville, Maryland, United States
View Trial Details

Related conditions